C07C - Acyclic or carbocyclic compounds

More topics under "C07C - Acyclic or carbocyclic compounds" (1,084,701)
C07C 1 - Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon (18,898)
C07C 11 - Acyclic unsaturated hydrocarbons (14,240)
C07C 13 - Cyclic hydrocarbons containing rings other than, or in addition to, six-membered aromatic rings (6,421)
C07C 15 - Cyclic hydrocarbons containing only six-membered aromatic rings as cyclic part (13,158)
C07C 17 - Preparation of halogenated hydrocarbons (19,929)
C07C 19 - Acyclic saturated compounds containing halogen atoms (7,734)
C07C 2 - Preparation of hydrocarbons from hydrocarbons containing a smaller number of carbon atoms (17,014)
C07C 201 - Preparation of esters of nitric or nitrous acid or of compounds containing nitro or nitroso groups bound to a carbon skeleton (5,786)
C07C 203 - Esters of nitric or nitrous acid (797)
C07C 205 - Compounds containing nitro groups bound to a carbon skeleton (11,422)
C07C 207 - Compounds containing nitroso groups bound to a carbon skeleton (222)
C07C 209 - Preparation of compounds containing amino groups bound to a carbon skeleton (17,459)
C07C 21 - Acyclic unsaturated compounds containing halogen atoms (4,465)
C07C 211 - Compounds containing amino groups bound to a carbon skeleton (24,007)
C07C 213 - Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton (12,264)
C07C 215 - Compounds containing amino and hydroxy groups bound to the same carbon skeleton (11,541)
C07C 217 - Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton (13,958)
C07C 219 - Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton (3,521)
C07C 22 - Cyclic compounds containing halogen atoms bound to an acyclic carbon atom (1,996)
C07C 221 - Preparation of compounds containing amino groups and doubly-bound oxygen atoms bound to the same carbon skeleton (1,346)
C07C 223 - Compounds containing amino and cho groups bound to the same carbon skeleton (590)
C07C 225 - Compounds containing amino groups and doubly-bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly-bound oxygen atoms not being part of a cho group, e.g. amino ketones (4,302)
C07C 227 - Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton (10,339)
C07C 229 - Compounds containing amino and carboxyl groups bound to the same carbon skeleton (21,416)
C07C 23 - Compounds containing at least one halogen atom bound to a ring other than a six-membered aromatic ring (1,237)
C07C 231 - Preparation of carboxylic acid amides (17,275)
C07C 233 - Carboxylic acid amides (28,881)
C07C 235 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms (15,664)
C07C 237 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups (16,118)
C07C 239 - Compounds containing nitrogen-to-halogen bonds; Hydroxylamino compounds or ethers or esters thereof (5,130)
C07C 241 - Preparation of compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes (2,288)
C07C 243 - Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes (2,826)
C07C 245 - Compounds containing chains of at least two nitrogen atoms with at least one nitrogen-to-nitrogen multiple bond (2,015)
C07C 247 - Compounds containing azido groups (1,388)
C07C 249 - Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton (3,537)
C07C 25 - Compounds containing at least one halogen atom bound to a six-membered aromatic ring (5,308)
C07C 251 - Compounds containing nitrogen atoms doubly- bound to a carbon skeleton (9,928)
C07C 253 - Preparation of carboxylic acid nitriles (14,307)
C07C 255 - Carboxylic acid nitriles (27,066)
C07C 257 - Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines (2,984)
C07C 259 - Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups (4,411)
C07C 261 - Derivatives of cyanic acid (932)
C07C 263 - Preparation of derivatives of isocyanic acid (3,065)
C07C 265 - Derivatives of isocyanic acid (3,263)
C07C 267 - Carbodiimides (400)
C07C 269 - Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups the nitrogen atom not being part of nitro or nitroso groups (4,512)
C07C 27 - Processes involving the simultaneous production of more than one class of oxygen-containing compounds (9,977)
C07C 271 - Derivatives of carbamic acid, i.e. compounds containing any of the groups the nitrogen atom not being part of nitro or nitroso groups (15,621)
C07C 273 - Preparation of urea or its derivatives, i.e. compounds containing any of the groups the nitrogen atoms not being part of nitro or nitroso groups (3,705)
C07C 275 - Derivatives of urea, i.e. compounds containing any of the groups the nitrogen atoms not being part of nitro or nitroso groups (9,848)
C07C 277 - Preparation of guanidine or its derivatives, i.e. compounds containing the group the singly-bound nitrogen atoms not being part of nitro or nitroso groups (1,361)
C07C 279 - Derivatives of guanidine, i.e. compounds containing the group the singly-bound nitrogen atoms not being part of nitro or nitroso groups (5,394)
C07C 281 - Derivatives of carbonic acid containing functional groups covered by groups in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group (2,117)
C07C 29 - Preparation of compounds having hydroxy or o-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring (31,270)
C07C 291 - Compounds containing carbon and nitrogen and having functional groups not covered by groups (1,596)
C07C 301 - Esters of sulfurous acid (2,612)
C07C 303 - Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides (11,473)
C07C 305 - Esters of sulfuric acids (2,034)
C07C 307 - Amides of sulfuric acids, i.e. compounds having singly-bound oxygen atoms of sulfate groups replaced by nitrogen atoms, not being part of nitro or nitroso groups (1,726)
C07C 309 - Sulfonic acids; Halides, esters, or anhydrides thereof (15,484)
C07C 31 - Saturated compounds having hydroxy or o-metal groups bound to acyclic carbon atoms (16,921)
C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups (17,647)
C07C 313 - Sulfinic acids; Sulfenic acids; Halides, esters or anhydrides thereof; Amides of sulfinic or sulfenic acids, i.e. compounds having singly-bound oxygen atoms of sulfinic or sulfenic groups replaced by nitrogen atoms, not being part of nitro or nitroso groups (5,772)
C07C 315 - Preparation of sulfones; Preparation of sulfoxides (4,234)
C07C 317 - Sulfones; Sulfoxides (15,874)
C07C 319 - Preparation of thiols, sulfides, hydropolysulfides or polysulfides (8,304)
C07C 321 - Thiols, sulfides, hydropolysulfides or polysulfides (3,793)
C07C 323 - Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups (27,160)
C07C 325 - Thioaldehydes; Thioketones; Thioquinones; Oxides thereof (2,089)
C07C 327 - Thiocarboxylic acids (5,460)
C07C 329 - Thiocarbonic acids; Halides, esters or anhydrides thereof (875)
C07C 33 - Unsaturated compounds having hydroxy or o-metal groups bound to acyclic carbon atoms (6,901)
C07C 331 - Derivatives of thiocyanic acid or of isothiocyanic acid (1,540)
C07C 333 - Derivatives of thiocarbamic acids, i.e. compounds containing any of the groups the nitrogen atom not being part of nitro or nitroso groups (2,223)
C07C 335 - Thioureas, i.e. compounds containing any of the groups the nitrogen atoms not being part of nitro or nitroso groups (3,175)
C07C 337 - Derivatives of thiocarbonic acids containing functional groups covered by groups or in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group (520)
C07C 35 - Compounds having at least one hydroxy or o-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring (4,656)
C07C 37 - Preparation of compounds having hydroxy or o-metal groups bound to a carbon atom of a six-membered aromatic ring (10,407)
C07C 381 - Compounds containing carbon and sulfur and having functional groups not covered by groups (2,888)
C07C 39 - Compounds having at least one hydroxy or o-metal group bound to a carbon atom of a six-membered aromatic ring (10,875)
C07C 391 - Compounds containing selenium (659)
C07C 395 - Compounds containing tellurium (180)
C07C 4 - Preparation of hydrocarbons from hydrocarbons containing a larger number of carbon atoms (5,080)
C07C 401 - Irradiation products of cholesterol or its derivatives; Vitamin d derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation (3,426)
C07C 403 - Derivatives of cyclohexane or of a cyclohexene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene rings, e.g. vitamin a, beta-carotene, beta-ionone (2,683)
C07C 405 - Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins (3,702)
C07C 407 - Preparation of peroxy compounds (1,613)
C07C 409 - Peroxy compounds (3,365)
C07C 41 - Preparation of ethers; Preparation of compounds having groups, groups or groups (17,242)
C07C 43 - Ethers; Compounds having groups, groups or groups (24,599)
C07C 45 - Preparation of compounds having co groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds (38,929)
C07C 46 - Preparation of quinones (1,836)
C07C 47 - Compounds having cho groups (13,190)
C07C 49 - Ketones; Ketenes; Dimeric ketenes; Ketonic chelates (22,686)
C07C 5 - Preparation of hydrocarbons from hydrocarbons containing the same number of carbon atoms (14,771)
C07C 50 - Quinones (2,441)
C07C 51 - Preparation of carboxylic acids or their salts, halides, or anhydrides (43,144)
C07C 53 - Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen (9,125)
C07C 55 - Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms (3,355)
C07C 57 - Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms (12,415)
C07C 59 - Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups oh, o-metal, cho, keto, ether, groups, groups, or groups (14,643)
C07C 6 - Preparation of hydrocarbons from hydrocarbons containing a different number of carbon atoms by redistribution reactions (4,092)
C07C 61 - Compounds having carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings (2,686)
C07C 62 - Compounds having carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings and containing any of the groups oh, o-metal, cho, keto, ether, groups, groups, or groups (1,753)
C07C 63 - Compounds having carboxyl groups bound to carbon atoms of six-membered aromatic rings (6,553)
C07C 65 - Compounds having carboxyl groups bound to carbon atoms of six-membered aromatic rings and containing any of the groups oh, o-metal, cho, keto, ether, groups, groups, or groups (5,447)
C07C 66 - Quinone carboxylic acids (322)
C07C 67 - Preparation of carboxylic acid esters (66,429)
C07C 68 - Preparation of esters of carbonic or haloformic acids (3,588)
C07C 69 - Esters of carboxylic acids; Esters of carbonic or haloformic acids (54,756)
C07C 7 - Purification, separation orstabilisation of hydrocarbons; Use of additives (13,802)
C07C 71 - Esters of oxyacids of halogens (78)
C07C 9 - Acyclic saturated hydrocarbons (5,219)

Patents for C07C - Acyclic or carbocyclic compounds (5,682)
01/2003
01/08/2003	EP1123276B1 N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them
01/08/2003	CN1390191A Hydroxyeicosatetraenoic acid analogs and methods of their use in treating dry eye disorders
12/2002
12/31/2002	US6500987 Sertraline hydrochloride polymorphs
12/25/2002	CN1096853C Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof
12/24/2002	US6498172 Prostaglandin agonists and their use to treat bone disorders
12/19/2002	WO2002100822A1 Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes
12/19/2002	WO2002100413A1 A PHARMACEUTICAL COMBINATION COMPRISING EITHER (S)-2-ETHOXY-3- [4-(2-{4-METHANE SULFONYL OXYPHENYL} ETHOXY) PHENYL] PROPANOIC ACID OR 3-{4-[2-(4-TERT- BUTOXY CARBONYL AMINOPHENYL) ETHOXY] PHENYL} -(s)-2-ETHOXY PROPANOIC ACID AND A SULONYLUREA
12/19/2002	CA2448763A1 A pharmaceutical combination comprising either (s)-2-ethoxy-3- [4-(2-{4-methane sulfonyl oxyphenyl} ethoxy) phenyl] propanoic acid or 3-{4-[2-(4-tert- butoxy carbonyl aminophenyl)ethoxy] phenyl} -(s)-2-ethoxy propanoic acid and a sulonylurea
12/19/2002	CA2445653A1 Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes
12/17/2002	US6495606 Administering s-((r)-2-(1-iminoethylamino)propyl)-l-cysteine
12/12/2002	US20020188133 Producing an isoxazolidinedione compound from beta - methyl L-aspartate via an important intermediate oxazolylethanol derivative
12/12/2002	US20020188122 Such as pyridine-4-carboxaldehyde-(4-Morpholinylprop-3-yl) imine for use in therapy as cytokine inhibitors
12/11/2002	EP1264827A1 Process for the preparation of Tosylbenzylformamides
12/11/2002	EP1263702A2 Treatment of fluorocarbon feedstocks
12/11/2002	EP1263699A1 Process for the production of olefins
12/11/2002	CN1384819A 前列腺素e类似物 E prostaglandin analogs
12/11/2002	CN1095835C Tricyclo-substituted isohydroxyloxime acid derivative
12/10/2002	US6492539 Preparation of preparing substituted indanones
12/05/2002	WO2002096865A1 Process for the preparation 3-aryl-2-hydroxypropionic acid derivative
12/05/2002	WO2002096453A1 A pharmaceutical combination comprising either (s)-2-ethoxy-3 [4-(2- {4-methane sulfonyl oxyphenyl} ethoxy)phenyl] propanoic acid or 3-{4-[2- (4-tert-butoxy carbonylamino phenyl) ethoxy] phenyl}-(s)-2-ethoxy propanoic acid and insulin
12/05/2002	WO2002096402A1 A pharmaceutical combination comprising either (s)-2-ethoxy-3- [4-(2- {4-methane sulfonyl oxyphenyl} ethoxy) phenyl] propanoic acid or 3-{4-[2- (4-tert-butoxy carbonyl aminophenyl) ethoxy] phenyl} -(s)-2-ethoxy propanoic acid and a biguanide drug
12/05/2002	US20020183553 Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof
12/05/2002	CA2448658A1 Process for the preparation 3-aryl-2-hydroxypropionic acid derivative
12/05/2002	CA2448643A1 A pharmaceutical combination comprising either (s)-2-ethoxy-3- [4-(2- {4-methane sulfonyl oxyphenyl} ethoxy) phenyl] propanoic acid or 3-{4-[2- (4-tert-butoxy carbonyl aminophenyl) ethoxy] phenyl} -(s)-2-ethoxy propanoic acid and a biguanide drug
12/05/2002	CA2448637A1 A pharmaceutical combination comprising either (s)-2-ethoxy-3 [4-(2- {4-methane sulfonyl oxyphenyl} ethoxy)phenyl] propanoic acid or 3-{4-[2- (4-tert-butoxy carbonylamino phenyl) ethoxy] phenyl}-(s)-2-ethoxy propanoic acid and insulin
11/2002
11/27/2002	EP1260511A1 Process for the preparation of 5-chloro-1-(4-fluorophenyl)-3-(1,2,3,6-tetrahydropyridin-4-yl)indole and method of manufacturing sertindole
11/27/2002	CN1382121A C16 unsaturated FP-selective prostaglandins analogs
11/27/2002	CN1382118A Biocyclic amino acids aspharmaceutical agents
11/19/2002	US6482990 Prostaglandin E analogues
11/19/2002	US6482976 Processes for conducting equilibrium-limited reactions
11/19/2002	US6482812 Method of locking 1α-OH of vitamin D compounds in axial orientation
11/14/2002	US20020169334 Mono, di or triesters of caroteonids, product of hydroxy carotenoid selected from the group consisting of monohydroxy, dihydroxy and polyhydroxy carotenoids and carboxylic carotenoid selected from mono, di or tricarboxylic carotenoids
11/14/2002	US20020169170 Arylpiperazines having activity at the serotonin 1A receptor
11/13/2002	EP0843672B1 One pot synthesis of 2-oxazolidinone derivatives
10/2002
10/31/2002	WO2002085839A1 Fused bicyclic or tricyclic amino acids
10/31/2002	WO2002085831A1 Process for the preparation of an xanthophyll
10/31/2002	CA2443945A1 Process for the preparation of an xanthophyll
10/30/2002	EP1253131A1 Process for the preparation of an xanthophyll
10/23/2002	EP1251127A1 Novel sidechain-bearing taxanes and intermediates thereof
10/16/2002	EP1249233A1 Npyy5 antagonists
10/16/2002	EP1248760A1 An eco-friendly method of preparation of high purity tetrabromobisphenol-a
10/16/2002	EP1248605A2 Novel sertraline hydrochloride polymorphs, processes for preparing them, compositions containing them and methods of using them
10/16/2002	CN1092657C One pot synthesis of 2-oxazolidinone derivatives
10/10/2002	WO2002079143A1 N-phenpropylcyclopentyl-substituted glutaramide derivatives as nep inhibitors for fsad
10/10/2002	CA2437113A1 N-phenpropylcyclopentyl-substituted glutaramide derivatives as nep inhibitors for fsad
10/09/2002	EP1247523A1 Essential fatty acids in the prevention of cardiovascular events
10/01/2002	US6458827 Adjustent of conformation equilibrium; active materials
09/2002
09/26/2002	US20020137774 Carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
09/25/2002	EP0975580B1 Contrast agent preparation
09/24/2002	US6455507 Benzimidazole derivatives
09/18/2002	EP1000052B1 Process for preparing 3-isochromanome
09/18/2002	EP0823889B1 1,3-propane diol derivatives as bioactive compounds
09/17/2002	US6452054 Psychological disorders
09/17/2002	US6451859 C16 unsaturated FP-selective prostaglandins analogs
09/17/2002	US6451340 Nucleotide analog compositions
09/17/2002	CA2339311C Process for preparing improved nickel catalysts for use in hydrogenation reactions
09/10/2002	US6448277 VEGF receptor tyrosine kinase inhibitors
09/06/2002	WO2002068385A2 Novel carotenoid esters
09/04/2002	EP1235832A1 Vitamin d prescursors, method and intermediates
09/04/2002	EP1235787A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS
09/03/2002	US6444827 From beta-methyl l-aspartate via chemical intermediate; efficiency; antidiabetic agents
08/2002
08/28/2002	EP0822927B1 A process for the preparation of tetrabromobisphenol-a
08/28/2002	CN1089761C Sidechain-bearing texanes and its preparing process
08/27/2002	US6441207 Method for making hydroxy-25-ene-vitamin D compounds
08/27/2002	US6440440 Biocidal benzylbiphenyl derivatives
08/07/2002	EP1228029A1 Hydroxyeicosatetraenoic acid analogs and methods of their use in treating dry eye disorders
08/07/2002	EP0984922B1 Preparation of tri-iodo benzene compounds
08/07/2002	EP0801649B1 Hydroxylamine derivatives useful for enhancing the molecular chaperon production and the preparation thereof
08/07/2002	CN1362398A Preparation method for cyclopropanates
08/01/2002	US20020103171 7-and 9- carbamate, urea, thiourea, thiocarbamate, and heteroaryl-amino substituted tetracycline compounds
07/2002
07/31/2002	EP1227095A2 A process for the purification of (S)-4-((3-(dimethylamino)ethyl)-1H-indol-5yl)-methyl)-2-oxazolidinone
07/31/2002	EP1226110A1 Bicyclic amino acids as pharmaceutical agents
07/31/2002	CN1361765A Inhibitors of aspartyl protease
07/31/2002	CN1360890A Use of active retiene derivative with negative hormone and/or antagonist
07/30/2002	US6426440 Hydrogen chloride and vinyl chloride gases are cooled to 150-180 degree c, the uncondensed predominant 1,2-dichloroethane is distilled and fed for benzene chlorination
07/25/2002	WO2002057207A1 An eco-friendly method of preparation of high purity tetrabromobisphenol-a
07/25/2002	CA2435132A1 Compositions comprising higher diamondoids and processes for their separation
07/25/2002	CA2434941A1 Compositions comprising cyclohexamantane
07/18/2002	US20020094963 Benzimidazole derivatives
07/16/2002	US6420600 Hydroxyalkylphenyldiamides
07/16/2002	US6419710 Mixture containing oxidoreductase enzyme
07/11/2002	US20020090868 System and method for the production and use of hydrogen on board a marine vessel .
07/09/2002	CA2041224C Azatetracycle compounds
07/04/2002	WO2002014248A3 Bicyclic phosphin comprising hydroformylation catalyst and use thereof in production of oxygenated products
07/04/2002	WO2001045692A9 Novel sertraline hydrochloride polymorphs, processes for preparing them, compositions containing them and methods of using them
07/04/2002	US20020086378 Generation of acetic acid; obtain acetogenic bacteria, remove carbon dioxide from fermentation broth, incubate broth with solvent, continuously distill acetic acid from solvent
07/03/2002	CN1356897A Method of treating sleep apnoea
06/2002
06/26/2002	CN1355784A Mono-and-disubstituted 2-pyrolyl gamma-aminobutric acids
06/25/2002	US6410780 C11 oxymyl and hydroxylamino prostaglandins useful as medicaments
06/13/2002	US20020072639 Process for the crystallisation of sterically hindered compounds
06/13/2002	DE10041671C1 Verfahren zur Herstellung von Imidazo[1,2-c][2,3]benzodiazepinen sowie Phenylessigsäureester und Oxazol-Derivate als Zwischenprodukte bei deren Herstellung Benzodiazepines process for the preparation of imidazo [1,2-c] [2,3] oxazole and phenylacetic acid esters and derivatives, as intermediates in the preparation thereof
06/12/2002	EP1213288A1 Propanoic acid derivatives that inhibit the binding of integrins to their receptors
06/12/2002	EP1212296A1 Phosphate mimics and methods of treatment using phosphatase inhibitors
06/12/2002	EP0914316B1 Process for the production of irones
06/12/2002	CN1353691A Cell adhesion-inhibiting anti inflammatory and immune-suppresive compounds
06/12/2002	CN1353603A Method of controlling weight gain associated with therapeutic drugs
06/06/2002	US20020068723 Altering the conformational equilibrium of the A- ring to favor a chair conformation that presents the 1 alpha-hydroxyl in the axial orientation.
06/05/2002	EP1211241A1 Prostaglandin e analogues
06/05/2002	EP0909268B1 Method for preparing substituted anthraquinone and application to the preparation of rheins
06/05/2002	CN1352553A Weight loss after pregnancy

1 ... 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 ... 57